154 related articles for article (PubMed ID: 35435021)
1. Atrial Electrical Remodeling in Mice With Cardiac-Specific Overexpression of Angiotensin II Type 1 Receptor.
Demers J; Ton AT; Huynh F; Thibault S; Ducharme A; Paradis P; Nemer M; Fiset C
J Am Heart Assoc; 2022 Apr; 11(8):e023974. PubMed ID: 35435021
[TBL] [Abstract][Full Text] [Related]
2. Reduction in Na(+) current by angiotensin II is mediated by PKCα in mouse and human-induced pluripotent stem cell-derived cardiomyocytes.
Mathieu S; El Khoury N; Rivard K; Gélinas R; Goyette P; Paradis P; Nemer M; Fiset C
Heart Rhythm; 2016 Jun; 13(6):1346-54. PubMed ID: 26921763
[TBL] [Abstract][Full Text] [Related]
3. Distinct patterns of atrial electrical and structural remodeling in angiotensin II mediated atrial fibrillation.
Jansen HJ; Mackasey M; Moghtadaei M; Belke DD; Egom EE; Tuomi JM; Rafferty SA; Kirkby AW; Rose RA
J Mol Cell Cardiol; 2018 Nov; 124():12-25. PubMed ID: 30273558
[TBL] [Abstract][Full Text] [Related]
4. Immunoproteasome Subunit β5i Promotes Ang II (Angiotensin II)-Induced Atrial Fibrillation by Targeting ATRAP (Ang II Type I Receptor-Associated Protein) Degradation in Mice.
Li J; Wang S; Zhang YL; Bai J; Lin QY; Liu RS; Yu XH; Li HH
Hypertension; 2019 Jan; 73(1):92-101. PubMed ID: 30571551
[TBL] [Abstract][Full Text] [Related]
5. Loss of insulin signaling may contribute to atrial fibrillation and atrial electrical remodeling in type 1 diabetes.
Polina I; Jansen HJ; Li T; Moghtadaei M; Bohne LJ; Liu Y; Krishnaswamy P; Egom EE; Belke DD; Rafferty SA; Ezeani M; Gillis AM; Rose RA
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7990-8000. PubMed ID: 32198206
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil Does Not Prevent Heart Hypertrophy and Fibrosis Induced by Cardiomyocyte Angiotensin II Type 1 Receptor Signaling.
Straubinger J; Schöttle V; Bork N; Subramanian H; Dünnes S; Russwurm M; Gawaz M; Friebe A; Nemer M; Nikolaev VO; Lukowski R
J Pharmacol Exp Ther; 2015 Sep; 354(3):406-16. PubMed ID: 26157043
[TBL] [Abstract][Full Text] [Related]
7. NPR-C (Natriuretic Peptide Receptor-C) Modulates the Progression of Angiotensin II-Mediated Atrial Fibrillation and Atrial Remodeling in Mice.
Jansen HJ; Mackasey M; Moghtadaei M; Liu Y; Kaur J; Egom EE; Tuomi JM; Rafferty SA; Kirkby AW; Rose RA
Circ Arrhythm Electrophysiol; 2019 Jan; 12(1):e006863. PubMed ID: 30636477
[TBL] [Abstract][Full Text] [Related]
8. High hydrostatic pressure induces atrial electrical remodeling through angiotensin upregulation mediating FAK/Src pathway activation.
Li X; Deng CY; Xue YM; Yang H; Wei W; Liu FZ; Guo HM; Liu Y; Wang ZY; Zhang MZ; Wu SL; Rao F
J Mol Cell Cardiol; 2020 Mar; 140():10-21. PubMed ID: 32006532
[TBL] [Abstract][Full Text] [Related]
9. Effect of angiotensin II receptor 1 antisense oligodoexynucleotides on physiological and pathophysiological growth of cardiomyocytes.
Wang Y; Wang JM; Yan SX; Li MJ; Li JJ
Acta Pharmacol Sin; 2004 May; 25(5):561-9. PubMed ID: 15132819
[TBL] [Abstract][Full Text] [Related]
10. Chronic HDAC6 Activation Induces Atrial Fibrillation Through Atrial Electrical and Structural Remodeling in Transgenic Mice.
Sawa Y; Matsushita N; Sato S; Ishida N; Saito M; Sanbe A; Morino Y; Taira E; Obara M; Hirose M
Int Heart J; 2021; 62(3):616-626. PubMed ID: 34054002
[TBL] [Abstract][Full Text] [Related]
11. Activin Receptor-Like Kinase 4 Haplodeficiency Mitigates Arrhythmogenic Atrial Remodeling and Vulnerability to Atrial Fibrillation in Cardiac Pathological Hypertrophy.
Wang Q; Chen Y; Zhang D; Li C; Chen X; Hou J; Fei Y; Wang Y; Li Y
J Am Heart Assoc; 2018 Aug; 7(16):e008842. PubMed ID: 30369314
[TBL] [Abstract][Full Text] [Related]
12. Cardiac-specific overexpression of the human type 1 angiotensin II receptor causes delayed repolarization.
Rivard K; Paradis P; Nemer M; Fiset C
Cardiovasc Res; 2008 Apr; 78(1):53-62. PubMed ID: 18245065
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models.
Gu J; Liu X; Wang QX; Guo M; Liu F; Song ZP; Zhang DD
J Mol Cell Cardiol; 2013 Dec; 65():1-8. PubMed ID: 24100253
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-(1-7) prevent atrial tachycardia induced sodium channel remodeling.
Wang X; Li G
Pacing Clin Electrophysiol; 2014 Oct; 37(10):1349-56. PubMed ID: 24861429
[TBL] [Abstract][Full Text] [Related]
15. Effects of irbesartan on gene expression revealed by transcriptome analysis of left atrial tissue in a porcine model of acute rapid pacing in vivo.
Chilukoti RK; Mostertz J; Bukowska A; Aderkast C; Felix SB; Busch M; Völker U; Goette A; Wolke C; Homuth G; Lendeckel U
Int J Cardiol; 2013 Oct; 168(3):2100-8. PubMed ID: 23414741
[TBL] [Abstract][Full Text] [Related]
16. Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6-Mediated Changes in Connexin Expression.
Lazzerini PE; Laghi-Pasini F; Acampa M; Srivastava U; Bertolozzi I; Giabbani B; Finizola F; Vanni F; Dokollari A; Natale M; Cevenini G; Selvi E; Migliacci N; Maccherini M; Boutjdir M; Capecchi PL
J Am Heart Assoc; 2019 Aug; 8(16):e011006. PubMed ID: 31423933
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiologic and molecular mechanisms of a frameshift NPPA mutation linked with familial atrial fibrillation.
Menon A; Hong L; Savio-Galimberti E; Sridhar A; Youn SW; Zhang M; Kor K; Blair M; Kupershmidt S; Darbar D
J Mol Cell Cardiol; 2019 Jul; 132():24-35. PubMed ID: 31077706
[TBL] [Abstract][Full Text] [Related]
18. Electrical and structural remodeling contribute to atrial fibrillation in type 2 diabetic db/db mice.
Bohne LJ; Jansen HJ; Daniel I; Dorey TW; Moghtadaei M; Belke DD; Ezeani M; Rose RA
Heart Rhythm; 2021 Jan; 18(1):118-129. PubMed ID: 32911049
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway.
Diniz GP; Carneiro-Ramos MS; Barreto-Chaves ML
Basic Res Cardiol; 2009 Nov; 104(6):653-67. PubMed ID: 19588183
[TBL] [Abstract][Full Text] [Related]
20. Activation of voltage-gated sodium current and inhibition of erg-mediated potassium current caused by telmisartan, an antagonist of angiotensin II type-1 receptor, in HL-1 atrial cardiomyocytes.
Chang WT; Wu SN
Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):797-807. PubMed ID: 29617054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
